Home » Third Time’s the Charm? Not For Alimera’s Eye Treatment
Third Time’s the Charm? Not For Alimera’s Eye Treatment
November 7, 2013
The FDA has issued a third complete response letter to Alimera, asking for additional clinical trial data to address certain statistical deficiencies with the drugmaker’s Iluvien macular edema treatment.